Sequential Management with Gonadotropin-Releasing Hormone Agonist and Dienogest of Endometriosis-Associated Uterine Myoma and Adenomyosis

In: Endometriosis - Basic Concepts and Current Research Trends · 2012 · doi:10.5772/29647 · W1513058898
OA: hybrid CC0 ⤵ 1 in-corpus citation
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This study investigated the efficacy of sequential treatment with a GnRH agonist followed by dienogest for endometriosis-associated uterine myoma and adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-27 · read from full text ⓘ

This chapter evaluates the sequential therapeutic approach combining gonadotropin-releasing hormone agonists with dienogest for managing patients presenting with both endometriosis-associated uterine myomas and adenomyosis. The authors outline a protocol designed to shrink fibroid tissue and alleviate symptoms associated with adenomyotic lesions through hormonal suppression followed by maintenance therapy. The text emphasizes that this combined strategy offers an alternative to immediate surgical intervention, particularly for women wishing to preserve fertility or avoid hysterectomy. This paper is centrally about endometriosis and adenomyosis, specifically focusing on the medical management of co-occurring uterine myomas alongside these conditions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Sequential Management with Gonadotropin-Releasing Hormone Agonist and Dienogest of Endometriosis-Associated Uterine Myoma and Adenomyosis
Full text 531 characters · extracted from oa-doi-fallback · click to expand
Open access Submitted: 10 March 2011 Published: 09 May 2012 DOI: 10.5772/29647 From the Edited Volume Edited by Koel Chaudhury and Baidyanath Chakravarty Submitted: 10 March 2011 Published: 09 May 2012 © 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Discover 2026 Nobel Laureate Francis Halzen’s chapter on IntechOpen >

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (24)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK